Great new article about GLP-1 in NY Times about their various uses and the science around GLP-1s

A few of the points stood out to me. However, GLP-1 receptors are present in a far wider range of organs, which suggests additional weight-loss mechanisms are likely still waiting to be identified. The question of why GLP-1 drugs can improve health independently of weight loss resists tidy explanations and leaves researchers puzzled. I have not encountered any other medical story in which scientists so often find themselves apologizing for how confusing their findings look. Every effect they investigate leads them toward a different account of how these drugs deliver benefits. Sometimes GLP-1s appear to act directly on the organs tied to particular diseases, improving their health. In other instances, the drugs assist the body in managing blood sugar and fat, which makes people “more metabolically flexible” and “biochemically more youthful,” according to Dr. DiMarchi. Among the most puzzling and intriguing mechanisms is their action on inflammation. Inflammation forms part of the body's built-in reaction to injury and infection. It can be a sign of healing, yet in chronic disease it may also be present and cause harm. At the University of Toronto, Dr. Drucker's lab has shifted away from researching chronic conditions such as diabetes and obesity toward deciphering how GLP-1s affect the immune system. “We realized very quickly one underlying theme of all these was inflammation,” he said, referring to those diseases.
 
CNCCurrency said:

A few of the points stood out to me. However, GLP-1 receptors are present in a far wider range of organs, which suggests additional weight-loss mechanisms are likely still waiting to be identified. The question of why GLP-1 drugs can improve health independently of weight loss resists tidy explanations and leaves researchers puzzled. I have not encountered any other medical story in which scientists so often find themselves apologizing for how confusing their findings look. Every effect they investigate leads them toward a different account of how these drugs deliver benefits. Sometimes GLP-1s appear to act directly on the organs tied to particular diseases, improving their health. In other instances, the drugs assist the body in managing blood sugar and fat, which makes people “more metabolically flexible” and “biochemically more youthful,” according to Dr. DiMarchi. Among the most puzzling and intriguing mechanisms is their action on inflammation. Inflammation forms part of the body's built-in reaction to injury and infection. It can be a sign of healing, yet in chronic disease it may also be present and cause harm. At the University of Toronto, Dr. Drucker's lab has shifted away from researching chronic conditions such as diabetes and obesity toward deciphering how GLP-1s affect the immune system. “We realized very quickly one underlying theme of all these was inflammation,” he said, referring to those diseases.
chronic inflammation and elevated insulin from insulin resistance are closely linked,

Inflammation and diabetes

People often call the connection between diabetes and inflammation a "vicious cycle." Persistent low-grade inflammation serves as both a factor that can bring on insulin resistance and something that results from elevated blood sugar.

What the "Vicious Cycle" Means

According to research, inflammation and diabetes reinforce one another via multiple biological routes:

• Inflammation as a Cause: Pro-inflammatory proteins (cytokines) may disrupt insulin signaling. During ongoing chronic inflammation, your cells respond less effectively to insulin, which produces insulin resistance.

• Diabetes as a Cause: If blood sugar stays high over time, the body generates "oxidative stress." That stress prompts the immune system to put out additional inflammatory markers, causing further harm to tissues and blood vessels.

• The Role of Fat: Visceral fat (fat stored around organs) functions as an "active organ" that releases inflammatory molecules. That is why weight management is a main target for interrupting the cycle.
 
dickybob said:

https://www.nytimes.com/interactive...e_code=1.bFA.X4Kl.myphXHInxfJs&smid=url-share

A wide-ranging look at the many purposes GLP-1 drugs are now serving. Since it's a gifted NY Times link, ideally it will be accessible to all. The layout is quite out of the ordinary, so we'll have to wait and see.
The one I liked best:





70615b387ab50424c74a19eea02083500317b58d5c9375dfa0fca51a0dc0340b.webp


Even so, they did track down the rare cases of adverse effects. A different woman said: "I couldn’t relieve myself. It made my stomach hurt, like an intermittent cutting pain across my stomach."
 
Back
Top